SCHEMBL24254583

SCHEMBL24254583

CS(=O)(=O)c1ccc(OC(F)(F)F)c(N)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.45
G6PD P11413 1/20 0.45
IDE P14735 1/20 0.45
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP8 P22894 1/20 0.43
MMP13 P45452 1/20 0.43
ALDH1A1 P00352 1/20 0.42
F2 P00734 3/20 0.41
PRSS1 P07477 3/20 0.41
PRSS2 P07478 3/20 0.41
PRSS3 P35030 3/20 0.41
PTGS2 P35354 2/20 0.40
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23143746 0.87 G6PD (0.49) SMN1; SMN2G6PDIDEALDH1A1PTGS2
SCHEMBL6112909 0.85 CA2 (0.50) CA1CA2MMP1MMP2MMP9
SCHEMBL9980545 0.83 TNNI3K (0.52) SMN1; SMN2CA1CA2MMP1MMP2
SCHEMBL17374630 0.83 POLB (0.42) SMN1; SMN2CA1CA2MMP1MMP2
SCHEMBL30454747 0.80 KCNH2 (0.46) SMN1; SMN2PTGS2SLC6A4SLC6A3KCNH2
SCHEMBL25354604 0.80 KCNH2 (0.46) SMN1; SMN2PTGS2SLC6A4SLC6A3KCNH2
SCHEMBL3344604 0.79 CA1 (0.65) SMN1; SMN2G6PDIDECA1CA2
SCHEMBL18230961 0.78 FFAR4 (0.43) SMN1; SMN2ALDH1A1PTGS2KCNH2TMEM97
SCHEMBL28826127 0.77 SMN1; SMN2 (0.40) SMN1; SMN2KCNH2TMEM97SIGMAR1
SCHEMBL18230946 0.77 MAPT (0.44) SMN1; SMN2ALDH1A1PTGS2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022035804-A1 SUBSTITUTED 3-AMINO-4-METHYLBENZENESULFONAMIDES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 DANA-FARBER CANCER INSTITUTE, INC. (US) 2022-02-17 WO disclosed